234 related articles for article (PubMed ID: 19801633)
1. Cyclin D1 induction by benzo[a]pyrene-7,8-diol-9,10-epoxide via the phosphatidylinositol 3-kinase/Akt/MAPK- and p70s6k-dependent pathway promotes cell transformation and tumorigenesis.
Ding J; Ning B; Gong W; Wen W; Wu K; Liang J; He G; Huang S; Sun W; Han T; Huang L; Cao G; Wu M; Xie W; Wang H
J Biol Chem; 2009 Nov; 284(48):33311-9. PubMed ID: 19801633
[TBL] [Abstract][Full Text] [Related]
2. Black raspberry extracts inhibit benzo(a)pyrene diol-epoxide-induced activator protein 1 activation and VEGF transcription by targeting the phosphotidylinositol 3-kinase/Akt pathway.
Huang C; Li J; Song L; Zhang D; Tong Q; Ding M; Bowman L; Aziz R; Stoner GD
Cancer Res; 2006 Jan; 66(1):581-7. PubMed ID: 16397275
[TBL] [Abstract][Full Text] [Related]
3. Benzo[a]pyrene diol-epoxide (B[a]PDE) upregulates COX-2 expression through MAPKs/AP-1 and IKKbeta/NF-kappaB in mouse epidermal Cl41 cells.
Ouyang W; Ma Q; Li J; Zhang D; Ding J; Huang Y; Xing MM; Huang C
Mol Carcinog; 2007 Jan; 46(1):32-41. PubMed ID: 16921490
[TBL] [Abstract][Full Text] [Related]
4. A critical role of PI-3K/Akt/JNKs pathway in benzo[a]pyrene diol-epoxide (B[a]PDE)-induced AP-1 transactivation in mouse epidermal Cl41 cells.
Li J; Tang MS; Liu B; Shi X; Huang C
Oncogene; 2004 May; 23(22):3932-44. PubMed ID: 15021902
[TBL] [Abstract][Full Text] [Related]
5. Benzo[a]pyrene-7,8-diol-9,10-epoxide inhibits gap junction intercellular communication via phosphorylation of tumor progression locus 2 in WB-F344 rat liver epithelial cells.
Lee BK; Chung MY; Lee KW
Mol Carcinog; 2015 May; 54(5):351-8. PubMed ID: 24249418
[TBL] [Abstract][Full Text] [Related]
6. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH
Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555
[TBL] [Abstract][Full Text] [Related]
7. Benzo[a]pyrene-induced cell cycle progression is through ERKs/cyclin D1 pathway and requires the activation of JNKs and p38 mapk in human diploid lung fibroblasts.
Du HJ; Tang N; Liu BC; You BR; Shen FH; Ye M; Gao A; Huang Cs
Mol Cell Biochem; 2006 Jul; 287(1-2):79-89. PubMed ID: 16699726
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol-3 kinase/Akt/p70S6K/AP-1 signaling pathway mediated benzo(a)pyrene-induced cell cycle alternation via cell cycle regulatory proteins in human embryo lung fibroblasts.
Gao A; Liu B; Shi X; Jia X; Ye M; Jiao S; You B; Huang C
Toxicol Lett; 2007 Apr; 170(1):30-41. PubMed ID: 17383120
[TBL] [Abstract][Full Text] [Related]
9. Involvement of nuclear factor of activated T cells 3 (NFAT3) in cyclin D1 induction by B[a]PDE or B[a]PDE and ionizing radiation in mouse epidermal Cl 41 cells.
Ding J; Zhang R; Li J; Xue C; Huang C
Mol Cell Biochem; 2006 Jul; 287(1-2):117-25. PubMed ID: 16645724
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of polycyclic aromatic hydrocarbons on transactivation of AP-1 and NF-kappaB in mouse epidermal cl41 cells.
Li J; Chen H; Ke Q; Feng Z; Tang MS; Liu B; Amin S; Costa M; Huang C
Mol Carcinog; 2004 Jun; 40(2):104-15. PubMed ID: 15170815
[TBL] [Abstract][Full Text] [Related]
11. Cyanidin-3-glucoside suppresses B[a]PDE-induced cyclooxygenase-2 expression by directly inhibiting Fyn kinase activity.
Lim TG; Kwon JY; Kim J; Song NR; Lee KM; Heo YS; Lee HJ; Lee KW
Biochem Pharmacol; 2011 Jul; 82(2):167-74. PubMed ID: 21501596
[TBL] [Abstract][Full Text] [Related]
12. AP-1 regulates cyclin D1 and c-MYC transcription in an AKT-dependent manner in response to mTOR inhibition: role of AIP4/Itch-mediated JUNB degradation.
Vartanian R; Masri J; Martin J; Cloninger C; Holmes B; Artinian N; Funk A; Ruegg T; Gera J
Mol Cancer Res; 2011 Jan; 9(1):115-30. PubMed ID: 21135252
[TBL] [Abstract][Full Text] [Related]
13. PI3K/Akt/JNK/c-Jun signaling pathway is a mediator for arsenite-induced cyclin D1 expression and cell growth in human bronchial epithelial cells.
Ding J; Ning B; Huang Y; Zhang D; Li J; Chen CY; Huang C
Curr Cancer Drug Targets; 2009 Jun; 9(4):500-9. PubMed ID: 19519318
[TBL] [Abstract][Full Text] [Related]
14. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
[TBL] [Abstract][Full Text] [Related]
15. Direct evidence for the critical role of NFAT3 in benzo[a]pyrene diol-epoxide-induced cell transformation through mediation of inflammatory cytokine TNF induction in mouse epidermal Cl41 cells.
Ouyang W; Hu Y; Li J; Ding M; Lu Y; Zhang D; Yan Y; Song L; Qu Q; Desai D; Amin S; Huang C
Carcinogenesis; 2007 Oct; 28(10):2218-26. PubMed ID: 17522069
[TBL] [Abstract][Full Text] [Related]
16. L6 myoblast differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathway.
Sarker KP; Lee KY
Oncogene; 2004 Aug; 23(36):6064-70. PubMed ID: 15208659
[TBL] [Abstract][Full Text] [Related]
17. PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells.
Li J; Chen H; Tang MS; Shi X; Amin S; Desai D; Costa M; Huang C
J Cell Biol; 2004 Apr; 165(1):77-86. PubMed ID: 15067018
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts.
Takuwa N; Fukui Y; Takuwa Y
Mol Cell Biol; 1999 Feb; 19(2):1346-58. PubMed ID: 9891068
[TBL] [Abstract][Full Text] [Related]
19. Effects of anti-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on human small airway epithelial cells and the protective effects of myo-inositol.
Jyonouchi H; Sun S; Iijima K; Wang M; Hecht SS
Carcinogenesis; 1999 Jan; 20(1):139-45. PubMed ID: 9934861
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
